Eur Rev Med Pharmacol Sci 2019; 23 (3): 1176-1183

DOI: 10.26355/eurrev_201902_17010

Correlations of mouse lymphoma xenografts with the expressions of MMP-9 and Bcl-2

C.-L. Shi, X.-Y. Zhang, Y. Li, L.-L. Song, L. Wang

Department of Hematology, Qingdao Center Hospital, Qingdao, Shandong, P.R. China. lingwangling99@gmail.com


OBJECTIVE: To establish a mouse lymphoma xenograft model so as to investigate the correlation between the expression of matrix metallopeptidase-9 (MMP-9) and that of B-cell lymphoma 2 (Bcl-2) in lymphomas.

MATERIALS AND METHODS: Diffuse large Bcl (DLBCL) cells were cultured, and a mouse lymphoma xenograft model was established via the subcutaneous injection. Mouse lymphoma tissues were extracted, and the expressions of MMP-9 and Bcl-2 messenger ribonucleic acids (mRNAs) in the xenograft tumor were detected using Real-time polymerase chain reaction (PCR). Immunohistochemistry was used to detect the expression levels of MMP-9 and Bcl-2 proteins in lymphoma tissues and tumor-adjacent tissues. The consistency of MMP-9 expression and Bcl-2 expression was analyzed via Spearman’s rank correlation analysis.

RESULTS: The expressions of MMP-9 and Bcl-2 in lymphoma tissues were increased. The expression levels of MMP-9 and Bcl-2 proteins in lymphoma tissues were higher than those in tumor-adjacent tissues. The expression levels of MMP-9 and Bcl-2 were correlated with the body weight loss degree of mice, and the expression of MMP-9 was positively associated with that of BCL-2 in lymphomas.

CONCLUSIONS: MMP-9 and Bcl-2 are associated with the onset of DLBCL, and they are potential impact factors affecting the prognosis.

Free PDF Download

To cite this article

C.-L. Shi, X.-Y. Zhang, Y. Li, L.-L. Song, L. Wang
Correlations of mouse lymphoma xenografts with the expressions of MMP-9 and Bcl-2

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 3
Pages: 1176-1183
DOI: 10.26355/eurrev_201902_17010